当前位置: 首页 SCI期刊 SCIE期刊 JCRQ3 期刊介绍(非官网)
Global Journal Of Medical Pharmaceutical And Biomedical Update

Global Journal Of Medical Pharmaceutical And Biomedical UpdateSCIE

国际简称:GLOB J MED PHARM BIO  参考译名:全球医药和生物医学杂志更新

  • JCR分区

    Q3

基本信息:
ISSN:2765-8910
是否OA:未开放
是否预警:否
出版信息:
出版语言:English
研究方向:MEDICINE, GENERAL & INTERNAL
评价信息:
影响因子:0.4
发文数据:
Gold OA文章占比:36.73%
研究类文章占比:50.00%
年发文量:24
英文简介 期刊介绍 JCR分区 常见问题

英文简介Global Journal Of Medical Pharmaceutical And Biomedical Update期刊介绍

Global Journal of Medical, Pharmaceutical and Biomedical Update is an academic journal with significant influence in the fields of medicine, pharmacy and biomedical sciences. Committed to gathering the latest research results, innovative discoveries, and practical applications in these three fields worldwide. It covers a wide range of topics, including but not limited to new therapies and diagnostic technologies in clinical medicine, the latest advances in drug development, innovative applications of biomedical engineering, and research on public health policies.

Its characteristic lies in emphasizing interdisciplinary communication and cooperation. By publishing research papers from multiple disciplines such as medicine, pharmacy, biology, chemistry, and physics, the integration and collision of knowledge from different fields have been promoted, providing diverse ideas and methods for solving complex health problems. For example, in cancer treatment, research results on new drug development, radiation therapy technology improvement, and personalized treatment strategies based on biomarkers may be published simultaneously. It has an editorial team composed of internationally renowned experts and scholars who use strict academic standards and professional review processes to ensure the scientific, innovative, and practical nature of the published articles.

期刊简介Global Journal Of Medical Pharmaceutical And Biomedical Update期刊介绍

《Global Journal Of Medical Pharmaceutical And Biomedical Update》该刊近一年未被列入预警期刊名单,目前已被权威数据库SCIE收录,得到了广泛的认可。

该期刊投稿重要关注点:

  • 预计审稿时间:
  • SCIE
  • 非预警

JCR分区Global Journal Of Medical Pharmaceutical And Biomedical Update JCR分区

2023-2024 年最新版
按JIF指标学科分区 收录子集 分区 排名 百分位
学科:MEDICINE, GENERAL & INTERNAL ESCI Q3 234 / 325

28.2%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:MEDICINE, GENERAL & INTERNAL ESCI Q4 247 / 329

25.08%

JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异,此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此,JCR将期刊按照学科门类和影响因子分为不同的分区,这样读者可以根据自己的研究领域和需求选择合适的期刊。

历年影响因子趋势图

投稿常见问题